Zevra Therapeutics (KMPH) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 44 252 sessions, February 28, 2022 to February 28, 2023
- Largest daily move
- -14% close of November 10, 2022
- 1-year change
- -2% closing prices, February 28, 2022 to February 28, 2023
- 1-month change
- +5.4% closing prices, January 27, 2023 to February 28, 2023
Company Description
Zevra Therapeutics (Nasdaq: KMPH) is classified in the biotechnology industry within the Healthcare sector.
KMPH declined 2.0% in the 12 months to February 28, 2023. The last closing price was $5.81.
This page collects what Stock Titan holds for KMPH, including price data and latest news.
Stock Performance
Zevra Therapeutics (KMPH) closed at $5.81 on February 28, 2023. In the 12 months to February 28, 2023, the price lost 2.0%.
KMPH Metrics & Rankings
Price returns through February 28, 2023. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Zevra Therapeutics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, earnings. View all KMPH news →
SEC Filings
KMPH Company Profile & Sector Positioning
Zevra Therapeutics (KMPH) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing KMPH often look at related companies in the same sector, including Korro Bio, Inc. (KRRO), BridgeBio Oncology Therapeutics, Inc. (BBOT), Protalix BioTherapeutics, Inc. (PLX), Artiva Biotherapeutics, Inc. (ARTV), and Palisade Bio, Inc. (PALI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KMPH's relative position within its industry.